Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marla,Shapiro C M

第一单位： Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: MarlaMD@aol.com.

作者： Marla,Shapiro C M ^[1] ; Antonio,Cano ^[2] ; Rossella E,Nappi ^[3] ; Nanette,Santoro ^[4] ; Marci L,English ^[5] ; Shayna,Mancuso ^[6] ; Antonia,Morga ^[7] ; Emad,Siddiqui ^[8] ; Udaya,Valluri ^[9] ; Faith D,Ottery ^[10]

作者单位： Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: MarlaMD@aol.com. ^[1] Department of Paediatrics, Obstetrics and Gynaecology, University of Valencia - INCLIVA, Valencia, Spain. Electronic address: Antonio.Cano@uv.es. ^[2] Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Research Center for Reproductive Medicine and Gynecological Endocrinology - Menopause Unit, Fondazione Policlinico IRCCS S. Matteo, Pavia, Italy. Electronic address: nappi@rossellanappi.com. ^[3] Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: Nanette.santoro@cuanschutz.edu. ^[4] Astellas Pharma Global Development, Northbrook, IL, USA. Electronic address: marci.english@astellas.com. ^[5] Astellas Pharma Global Development, Northbrook, IL, USA. Electronic address: shayna.mancuso@astellas.com. ^[6] Astellas Pharma Europe Ltd, Addlestone, United Kingdom. Electronic address: antonia_morga@astellas.com. ^[7] Astellas Pharma Europe Ltd, Addlestone, United Kingdom. Electronic address: Emad.Siddiqui@astellas.com. ^[8] Astellas Pharma Global Development, Northbrook, IL, USA. Electronic address: udairam_v@hotmail.com. ^[9] Astellas Pharma Global Development, Northbrook, IL, USA. Electronic address: faith.ottery@astellas.com. ^[10]

关键词 Fezolinetant Menopause PROMIS SD SF 8b measure Sleep disturbance Sleep impairment Vasomotor symptoms